Reducing the ischemic time of donor hearts will decrease morbidity and costs of cardiac transplantations

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 6, 2010, Pages 945-947

  Rylski, Bartosz ^a   Berchtold Herz, Michael ^a   Olschewski, Manfred ^a   Zeh, Wolfgang ^b   Schlensak, Christian ^a   Siepe, Matthias ^a   Beyersdorf, Friedhelm ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Heart transplantation; Ischemic time

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE UTILIZATION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEMOFILTRATION; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORGAN DONOR; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COLD ISCHEMIA; COST SAVINGS; DRUG COSTS; FEMALE; GERMANY; HEART TRANSPLANTATION; HEMOFILTRATION; HOSPITAL COSTS; HUMANS; INTENSIVE CARE; INTRA-AORTIC BALLOON PUMPING; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE; LENGTH OF STAY; MALE; MIDDLE AGED; NITRIC OXIDE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954561087     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.223719     Document Type: Article

References (10)

1. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Rahmel AO, Kucheryavaya AY, Hertz Ml. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report - 2008. J Heart Lung Transplant 2008;27:943-956.
2. Del Rizzo DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, Kostuk WJ. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant 1999;18:310-319.
3. Morgan JA, John R, Weinberg AD, Kherani AR, Colletti NJ, Vigilance DW, Cheema FH, Bisleri G, Cosola T, Mancini DM, Oz MC, Edwards NM. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg 2003;126:1624-1633.
4. Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies RR, George I, Cheema FH, Mosca RS, Mital S, Ascheim DD, Argenziano M, Stewart AS, Oz MC, Naka Y. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2007;133:554-559.
5. Banner NR, Thomas HL, Curnow E, Hussey JC, Rogers CA, Bonser RS. The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation 2008;86:542-547.
6. Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M, Kaye D, Bergin PJ. Prolonged cardiac allograft ischemic time - no impact on long-term survival but at what cost? Clin Transplant 2007;21:321-329.
7. Shumway NE, Lower RR, Stofer RC. Transplantation of the heart. Adv Surg 1966;2:265-284.
8. Beyersdorf F. The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage. Cardiovasc Res 2009;83:262-268.
9. Mitropoulos FA, Odim J, Marelli D, Karandikar K, Gjertson D, Ardehali A, Kobashigawa J, Laks H. Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study. Eur J Cardiothorac Surg 2005;28:143-148.
10. Kur F, Beiras-Fernandez A, Meiser B, Uberfuhr P, Reichart B. Clinical heart transplantation with extended preservation time (>5 hours): experience with University of Wisconsin solution. Transplant Proc 2009;41:2247-2249.